Addus Homecare Corp (ADUS) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Addus Homecare Corp  (NASDAQ: ADUS)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Addus Homecare's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Addus Homecare's ROI in the second quarter of 2026?
Addus Homecare Corp achieved a return on average invested assets (ROI) of 8.21 % in its second quarter of 2026, this is above ADUS's average return on investment of 7.2%.
Addus Homecare Corp invested over the 12 months ending in its second quarter of 2026 $1,282 million

ROI has improved compared to 7.83% in the first quarter of 2026, due to net income growth.

Within the Healthcare sector 30 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 1082, from total ROI ranking in the first quarter of 2026 at 1123.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 8.42 % 15.76 % 27.5 % 41.57 % 36.79 %
Y / Y Net Income Change TTM 26.92 % 26.27 % 66.03 % 123.98 % 358.92 %
Investment (TTM) in Millions 1,288 1,286 1,288 1,266 1,258
Return On Investment (TTM) 8.21 % 7.83 % 7.57 % 6.8 % 7.02 %
ADUS's Overall Ranking # 1082 # 1123 # 911 # 1060 # 846
Seq. Investment Change TTM 0.6 % 0.52 % 0.62 % 6.55 % 7.42 %
Seq. Net Income Change TTM 5.57 % 4 % 11.97 % 3.24 % 5.03 %
Net Income (TTM) in Millions 105 100 96 86 83




Return On Investment ADUS's Ranking
Within: No.
Industry # 6
Sector # 31
Overall # 1082

Return On Investment Statistics
High Average Low
19.52 %
7.2 %
4.41 %
(Sep 30 2013)   (Sep 30 2016)







Financial Statements
Addus Homecare's II. Quarter Investments $ 1,288 Millions ADUS's Balance sheet
Addus Homecare's II. Quarter Income $ 28 Millions Quarterly ADUS's Income Statement
ADUS's Income by Division See ADUS's Income by Division


ADUS Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 1,288 1,257 840 771 797
Y / Y Investment Growth 2.47 % 49.69 % 8.85 % -3.22 % 6.87 %
Net Income in Millions 96 74 63 46 45
Y / Y Net Income Growth 30.32 % 17.73 % 35.83 % 1.99 % 36.2 %
Annual Return On Investment 7.45 % 5.86 % 7.45 % 5.97 % 5.66 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 7.45 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ADUS's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ADUS's Competitors
Subscribers only: Roi for Addus Homecare's Suppliers
Subscribers only: Return On Investment for ADUS's Customers

Other Ratios
ADUS's Roa ADUS's Inventory Turnover Ratio ADUS's Growth Rates ADUS's Dividend Statistics
ADUS's Profitability Ratios ADUS's Asset Turnover Ratio ADUS's Dividend Growth
ADUS's Roe ADUS's Valuation Ratios ADUS's Financial Strength Ratios ADUS's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %
Krystal Biotech Inc   19.16 %
Carlisle Companies Incorporated  18.88 %
Neurocrine Biosciences Inc   17.51 %
Intuitive Surgical Inc   17.11 %
Theravance Biopharma inc   17.10 %
Standard Biotools Inc   16.38 %
Inspire Medical Systems inc   16.34 %
Aveanna Healthcare Holdings Inc   16.32 %
Harmony Biosciences Holdings inc   15.85 %
Entera Bio Ltd   15.84 %
Nephros Inc   15.31 %
West Pharmaceutical Services Inc   15.29 %
Progyny Inc   15.25 %
Biolife Solutions Inc   14.83 %
Sbc Medical Group Holdings Incorporated  14.78 %


Date modified: 2026-09-26T07:09:40+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.